Pitobrutinib/Pitobrutinib (Zepali) buy one get one free activity authenticity and precautions

First of all, there is no reliable evidence in the current public formal channels and official information that there is official authorization or pharmaceutical companies launching a "buy one, get one free" promotion for pitubrutinib. Pitobrutinib is indicated for the treatment of relapsed/refractory B cell malignancies (such as mantle cell lymphoma MCL or chronic lymphocytic leukemia /small lymphocytic lymphoma CLL/SLL) The sale and distribution of prescription oncology drugs are strictly regulated. Its approval for marketing, indications and sales channels are subject to legal and regulatory restrictions. Any promotion claiming to be "buy one get one free", "super low price" or "big discount" should first arouse vigilance, because such high-priced prescription anti-cancer drugs are usually not publicly promoted.

Secondly, from the perspective of medical safety and compliance, purchasing such expensive and sensitive anti-tumor drugs through informal channels inherently carries serious risks. Public literature and regulatory agencies have repeatedly warned that when purchasing cancer drugs through unregulated online pharmacies or the "black market", you may buy counterfeit drugs, substandard drugs, and drugs that do not contain active ingredients. Not only are the efficacy not guaranteed, but there may also be serious adverse reactions due to impurities or wrong doses. Therefore, so-called "buy one, get one free" activities are often a cover for fraud or the circulation of counterfeit drugs, and patients' participation may very well endanger their health and treatment safety.

Third, if patients really consider using pitubrutinib, they should adhere to the following principles: first, obtain the drug through a formal medical institution with a physician's prescription; second, purchase the drug through a legal and compliant drug supply chain (such as a regular hospital pharmacy, approved import distributor); third, avoid any private channels or informal third-party platforms that use"very low prices" and "ultra-high discounts" as selling points. For expensive anti-tumor drugs, safety, drug authenticity, batch number, and packaging integrity are extremely important. When purchasing medicines, you should check key information such as outer packaging, anti-counterfeiting labels, instructions, and approval numbers, and keep purchase vouchers and transportation records for future verification or reimbursement/rights protection.

Finally, if you discover or are induced to participate in activities similar to "buy one, get one free", you should immediately increase your vigilance and consult your attending doctor or regular hospital pharmacy. Do not buy blindly due to price temptation, and do not adjust the dosage by yourself or believe in the propaganda that it is "much cheaper than regular channels". Because pitubrutinib is used for severe hematologic malignancies, incorrect use may result in loss of efficacy, increased toxicity, or serious complications. For patients and their families, ensuring treatment safety and drug compliance should be the top priority, rather than pursuing so-called "discounts."

Reference materials:https://go.drugbank.com/drugs/DB15059